Concepedia

Stéphane Bouchet

SB

39

Publications

2.1K

Citations

23

H-Index

2003

Active since

Affiliations

Inserm(Current)

Centre Hospitalier Universitaire de Bordeaux

Université de Bordeaux

Bordeaux Population Health

Hôpital Pellegrin

Stéphane Bouchet is an author at Inserm specializing in medicine, pharmacology, and oncology.

ORCID

Top concepts

Publications per year

2003–2022

39

Publications

39

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension

Christophe Guignabert, Carole Phan, Andrei Seferian et al. · Journal of Clinical Investigation · 2016 · 265 citations · Full text

, , +17

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

Stéphanie Dulucq, Stéphane Bouchet, Béatrice Turcq et al. · Blood · 2008 · 233 citations

Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS

Stéphane Bouchet, Emmanuelle Chauzit, Dominique Ducint et al. · Clinica Chimica Acta · 2011 · 170 citations

, , +15

High throughput routine determination of 17 tyrosine kinase inhibitors by LC–MS/MS

C Merienne, Marine Rousset, Dominique Ducint et al. · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 116 citations

, , +8

Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial

S. Prey, Khaled Ezzedine, A. Doussau et al. · British Journal of Dermatology · 2012 · 105 citations

Rows per page

1–5 of 39